Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.

Literature DB >> 25459581

Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.

Michelle Fox Huffaker¹, Wanda Phipatanakul².

Abstract

Over the past several decades, the evidence supporting rational pediatric asthma management has grown considerably. As more is learned about the various phenotypes of asthma, the complexity of management will continue to grow. This article focuses on the evidence supporting the current guidelines-based pediatric asthma management and explores the future of asthma management with respect to phenotypic heterogeneity and biologics.

Entities: Chemical Disease Gene Species

Keywords: Asthma; Asthma management; Biologics; Omalizumab; Pediatric asthma

Mesh：

Substances：

Year: 2014 PMID： 25459581 PMCID： PMC4254501 DOI： 10.1016/j.iac.2014.09.005

Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN： 0889-8561 Impact factor: 3.479

140 in total

1. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.

Authors: A Equi; I M Balfour-Lynn; A Bush; M Rosenthal
Journal: Lancet Date: 2002-09-28 Impact factor: 79.321

2. Response to montelukast among subgroups of children aged 2 to 14 years with asthma.

Authors: Katie A Meyer; Jean Marie Arduino; Nancy C Santanello; Barbara A Knorr; Hans Bisgaard
Journal: J Allergy Clin Immunol Date: 2003-04 Impact factor: 10.793

3. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

Authors: Johan C Kips; Brian J O'Connor; Stephen J Langley; Ashley Woodcock; Huib A M Kerstjens; Dirkje S Postma; Mel Danzig; Francis Cuss; Romain A Pauwels
Journal: Am J Respir Crit Care Med Date: 2003-03-20 Impact factor: 21.405

4. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

Authors: Lisa Saiman; Bruce C Marshall; Nicole Mayer-Hamblett; Jane L Burns; Alexandra L Quittner; Debra A Cibene; Sarah Coquillette; Ann Yunker Fieberg; Frank J Accurso; Preston W Campbell
Journal: JAMA Date: 2003-10-01 Impact factor: 56.272

Review 5. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.

Authors: E M Erin; T J Williams; P J Barnes; T T Hansel
Journal: Curr Drug Targets Inflamm Allergy Date: 2002-06

6. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma.

Authors: Barry Zimmerman; Anthony D'Urzo; Denis Bérubé
Journal: Pediatr Pulmonol Date: 2004-02

7. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.

Authors: Hans Bisgaard; David Allen; Janusz Milanowski; Ilia Kalev; Lisa Willits; Patricia Davies
Journal: Pediatrics Date: 2004-02 Impact factor: 7.124

Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.

1. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.

2. Response to montelukast among subgroups of children aged 2 to 14 years with asthma.

3. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

4. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

Review 5. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.

6. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma.

7. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.

8. Patient adherence and medical treatment outcomes: a meta-analysis.

9. Low-dose theophylline in childhood asthma: a placebo-controlled, double-blind study.

Review 10. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children.

Review 1. Taming Asthma in School-Aged Children: A Comprehensive Review.

2. Keeping Pace with Adolescent Asthma: A Practical Approach to Optimizing Care.